More articles from Drug Discovery and Translational Medicine

You have access
Dopamine D₃ Receptor Antagonist (GSK598809) Potentiates the Hypertensive Effects of Cocaine in Conscious, Freely-Moving Dogs
Nathan M. Appel, Shou-Hua Li, Tyson H. Holmes and Jane B. Acri

Journal of Pharmacology and Experimental Therapeutics September 2015, 354 (3) 484-492; DOI: https://doi.org/10.1124/jpet.115.224121
You have access
Characterization of JNJ-42847922, a Selective Orexin-2 Receptor Antagonist, as a Clinical Candidate for the Treatment of Insomnia
Pascal Bonaventure, Jonathan Shelton, Sujin Yun, Diane Nepomuceno, Steven Sutton, Leah Aluisio, Ian Fraser, Brian Lord, James Shoblock, Natalie Welty, Sandra R. Chaplan, Zuleima Aguilar, Robin Halter, Anthony Ndifor, Tatiana Koudriakova, Michele Rizzolio, Michael Letavic, Nicholas I. Carruthers, Timothy Lovenberg and Christine Dugovic

Journal of Pharmacology and Experimental Therapeutics September 2015, 354 (3) 471-482; DOI: https://doi.org/10.1124/jpet.115.225466
You have access
Orally Administered Mucolytic Drug l-Carbocisteine Inhibits Angiogenesis and Tumor Growth in Mice
Tomohiro Shinya, Tsubasa Yokota, Shiori Nakayama, Sayuri Oki, Junpei Mutoh, Satoru Takahashi and Keizo Sato

Journal of Pharmacology and Experimental Therapeutics September 2015, 354 (3) 269-278; DOI: https://doi.org/10.1124/jpet.115.224816
You have access
Antitumor Activity of a Novel Sphingosine-1-Phosphate 2 Antagonist, AB1, in Neuroblastoma
Mei-Hong Li, Rolf Swenson, Miriam Harel, Sampa Jana, Erik Stolarzewicz, Timothy Hla, Linda H. Shapiro and Fernando Ferrer

Journal of Pharmacology and Experimental Therapeutics September 2015, 354 (3) 261-268; DOI: https://doi.org/10.1124/jpet.115.224519
You have access
A Novel Modulator of Kv3 Potassium Channels Regulates the Firing of Parvalbumin-Positive Cortical Interneurons
Marcelo D. Rosato-Siri, Erika Zambello, Chiara Mutinelli, Nicoletta Garbati, Roberto Benedetti, Laura Aldegheri, Francesca Graziani, Caterina Virginio, Giuseppe Alvaro and Charles H. Large

Journal of Pharmacology and Experimental Therapeutics September 2015, 354 (3) 251-260; DOI: https://doi.org/10.1124/jpet.115.225748
You have access
The Novel Anticancer Drug Hydroxytriolein Inhibits Lung Cancer Cell Proliferation via a Protein Kinase Cα– and Extracellular Signal-Regulated Kinase 1/2–Dependent Mechanism
Francisca Guardiola-Serrano, Roberto Beteta-Göbel, Raquel Rodríguez-Lorca, Maitane Ibarguren, David J. López, Silvia Terés, Rafael Alvarez, María Alonso-Sande, Xavier Busquets and Pablo V. Escribá

Journal of Pharmacology and Experimental Therapeutics August 2015, 354 (2) 213-224; DOI: https://doi.org/10.1124/jpet.114.222281
You have access
Bioengineering Novel Chimeric microRNA-34a for Prodrug Cancer Therapy: High-Yield Expression and Purification, and Structural and Functional Characterization
Wei-Peng Wang, Pui Yan Ho, Qiu-Xia Chen, Balasubrahmanyam Addepalli, Patrick A. Limbach, Mei-Mei Li, Wen-Juan Wu, Joseph L. Jilek, Jing-Xin Qiu, Hong-Jian Zhang, Tianhong Li, Theodore Wun, Ralph DeVere White, Kit S. Lam and Ai-Ming Yu

Journal of Pharmacology and Experimental Therapeutics August 2015, 354 (2) 131-141; DOI: https://doi.org/10.1124/jpet.115.225631
You have access
Humanized Thymidine Kinase–NOG Mice Can Be Used to Identify Drugs That Cause Animal-Specific Hepatotoxicity: A Case Study with Furosemide
Dan Xu, Sara A. Michie, Ming Zheng, Saori Takeda, Manhong Wu and Gary Peltz

Journal of Pharmacology and Experimental Therapeutics July 2015, 354 (1) 73-78; DOI: https://doi.org/10.1124/jpet.115.224493
You have access
Altering Metabolic Profiles of Drugs by Precision Deuteration: Reducing Mechanism-Based Inhibition of CYP2D6 by Paroxetine
Vinita Uttamsingh, Richard Gallegos, Julie F. Liu, Scott L. Harbeson, Gary W. Bridson, Changfu Cheng, David S. Wells, Philip B. Graham, Robert Zelle and Roger Tung

Journal of Pharmacology and Experimental Therapeutics July 2015, 354 (1) 43-54; DOI: https://doi.org/10.1124/jpet.115.223768
You have access
Semimechanistic Cell-Cycle Type–Based Pharmacokinetic/Pharmacodynamic Model of Chemotherapy-Induced Neutropenic Effects of Diflomotecan under Different Dosing Schedules
Víctor Mangas-Sanjuan, Núria Buil-Bruna, María J. Garrido, Elena Soto and Iñaki F. Trocóniz

Journal of Pharmacology and Experimental Therapeutics July 2015, 354 (1) 55-64; DOI: https://doi.org/10.1124/jpet.115.223776

Main menu

User menu

Search

More articles from Drug Discovery and Translational Medicine

Pages

Navigate

More Information

ASPET's Other Journals